Evaluating the Effects of Tasimelteon vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD)
Clinical trial NCT04652882 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04652882
- Sponsor
- Vanda Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-09
- Primary completion
- 2026-09-01
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.